Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-adamantan-1-yl-3-{5-[2-(2-ethoxy-ethoxy)-ethoxy]-pentyl}-urea | i.e. AEPU, shows beneficial effects in cardiac hypertrophy, evaluation in a clinically relevant murine model of myocardial infarction, overview | Mus musculus | |
trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid | i.e. tAUCB, shows beneficial effects in cardiac hypertrophy, evaluation in a clinically relevant murine model of myocardial infarction, overview | Mus musculus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
soluble | - |
Mus musculus | - |
- |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Mus musculus | sEH catalyzes the conversion of epoxyeicosatrienoic acids, EETs, to form the corresponding dihydroxyeicosatrienoic acids, DHETs | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | P34914 | male C57BL/6J mice | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
additional information | clinically relevant murine model of myocardial infarction | Mus musculus | - |
myocardium | - |
Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | sEH catalyzes the conversion of epoxyeicosatrienoic acids, EETs, to form the corresponding dihydroxyeicosatrienoic acids, DHETs | Mus musculus | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
SEH | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
malfunction | beneficial effects of several potent soluble epoxide hydrolase inhibitors in cardiac hypertrophy | Mus musculus |